Correlation Between HUTCHMED DRC and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and BioNTech SE, you can compare the effects of market volatilities on HUTCHMED DRC and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and BioNTech.

Diversification Opportunities for HUTCHMED DRC and BioNTech

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between HUTCHMED and BioNTech is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and BioNTech go up and down completely randomly.

Pair Corralation between HUTCHMED DRC and BioNTech

Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 15.39 times less return on investment than BioNTech. But when comparing it to its historical volatility, HUTCHMED DRC is 1.06 times less risky than BioNTech. It trades about 0.0 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  10,500  in BioNTech SE on September 12, 2024 and sell it today you would earn a total of  1,360  from holding BioNTech SE or generate 12.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HUTCHMED DRC  vs.  BioNTech SE

 Performance 
       Timeline  
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
BioNTech SE 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.

HUTCHMED DRC and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUTCHMED DRC and BioNTech

The main advantage of trading using opposite HUTCHMED DRC and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind HUTCHMED DRC and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like